Status:
COMPLETED
A Drug-Drug Interaction Study of Digoxin and PA21
Lead Sponsor:
Vifor Pharma
Conditions:
Drug Interaction Potentiation
Eligibility:
All Genders
20-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine if Digoxin is affected by PA21.
Eligibility Criteria
Inclusion
- Healthy volunteers
- Written informed consent
Exclusion
- No significant medical conditions
- Pregnancy
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01477411
Start Date
November 1 2011
End Date
January 1 2012
Last Update
January 18 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ACRI - Phase 1
Anaheim, California, United States, 92801